Back
ProShares Ultra Nasdaq Biotechnology Vs. ProShares Ultra Real Estate Industry Stock Comparison
Sell
37
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
56.87
Seasonality Move:
16.48%
Buy
68
URE
ProShares Ultra Real Estate
Last Price:
73.16
Seasonality Move:
4.21%
Sell
37
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $56.84. The Score for BIB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
ProShares Ultra Real Estate (URE)
is a Buy
Is ProShares Ultra Real Estate a Buy, Sell or Hold?
- The current ProShares Ultra Real Estate [URE] share price is $73.22. The Score for URE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- URE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $56.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
URE Stock Price Chart
What is ProShares Ultra Real Estate's stock price today?
-
The ProShares Ultra Real Estate share price today is $73.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URE is experiencing slight buying pressure.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.23 | Sell |
| Relative Strength Index (14 RSI): | 40.34 | Sell |
| Chaikin Money Flow: | 6112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.84 - 64.84) | Sell |
| Bollinger Bands (100): | (60.25 - 66.99) | Sell |
URE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 54.34 | Buy |
| Chaikin Money Flow: | 365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.07 - 73.55) | Buy |
| Bollinger Bands (100): | (64.98 - 75.22) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.94 | Buy |
| 20-day SMA: | 60.43 | Sell |
| 50-day SMA: | 62.42 | Sell |
| 200-day SMA: | 59.92 | Sell |
| 8-day EMA: | 56.66 | Buy |
| 20-day EMA: | 59.27 | Sell |
| 50-day EMA: | 61.48 | Sell |
| 200-day EMA: | 60.14 | Sell |
URE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.12 | Buy |
| 20-day SMA: | 71.29 | Buy |
| 50-day SMA: | 73.24 | Sell |
| 200-day SMA: | 63.28 | Buy |
| 8-day EMA: | 71.62 | Buy |
| 20-day EMA: | 71.66 | Buy |
| 50-day EMA: | 71.74 | Buy |
| 200-day EMA: | 65.58 | Buy |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Real Estate Earnings Growth & URE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Real Estate Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||